Biologics Regulatory MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants byJosh SandbergJune 20, 2024
Recon Regulatory Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants byJosh SandbergApril 8, 2024
Regulatory Top Stories MCRA Assists Active Life Scientific with Clinical Study Execution and Successful De Novo Decision for the OsteoProbe – A New Tool to Measure Bone Tissue byJosh SandbergDecember 8, 2021
Recon Zimmer Biomet and Canary Medical Announce FDA De Novo Classification Grant and Authorization to Market the World’s First and Only Smart Knee Implant byJosh SandbergAugust 30, 2021
Regulatory Spine Top Stories Intellirod Spine Receives First-Ever Spine FDA De Novo Approval byJosh SandbergApril 1, 2019
